About Path

Our Work and Why It Matters

The Partnership for the Accurate Testing of Hormones (PATH) formed in 2010 to help the clinical, medical and public health communities improve patient care through more accurate and reliable hormone tests. Our vision: Improved patient care through the universal use of accurate and reliable hormone tests in healthcare and research. 

We support research that improves the diagnosis and treatment of conditions related to having too much or too little of a certain hormone. Recently we supported a workshop to establish needed reference ranges for estradiol. Previously we also led a landmark study that defines a “normal” range of testosterone in young adult men.

We provide technical and scientific support to the CDC’s Hormone Standardization Program. This initiative focuses on improving measurements of testosterone, vitamin D and estradiol (a female sex hormone) in patient care and research and improving the diagnosis of polycystic ovary syndrome (PCOS) and certain hormone-related cancers.

We help doctors and the public become aware of the quality deficiencies in most of today’s tests. We educate health and medical professionals about the need for a generally accepted performance standard and the technical and policy barriers that stand in the way of better testing.

In our community and with industry, policymakers, media and the general public, we seek to advance the development of standardized hormone assays and to seek universal adoptions of those assays in medical practice and research.

Our Partners